Administration of steroids in pediatric cardiac surgery: impact on clinical outcome and systemic inflammatory

P Gessler1, V Hohl, T Carrel

  • 1University Children's Hospital, Steinwiesstrasse 75, CH 8032 Zurich, Switzerland. peter.gessler@kispi.unizh.ch

Pediatric Cardiology
|February 4, 2005
PubMed

Insights

Pre-bypass steroid administration did not improve postoperative recovery in infants undergoing heart surgery. Prednisolone did not significantly impact inflammatory markers or clinical outcomes following cardiopulmonary bypass (CPB).

Area of Science:

  • Pediatric Cardiovascular Surgery
  • Critical Care Medicine
  • Pharmacology

Background:

  • Cardiopulmonary bypass (CPB) triggers a systemic inflammatory response in infants undergoing heart surgery.
  • Pre-bypass steroid administration is hypothesized to mitigate this inflammation and enhance postoperative recovery.
  • The efficacy of perioperative steroids in pediatric cardiac surgery remains an area of investigation.

Purpose of the Study:

  • To evaluate the impact of prednisolone administration during cardiopulmonary bypass on postoperative recovery in infants undergoing heart surgery.
  • To assess whether pre-bypass steroid administration modulates the inflammatory response associated with CPB.
  • To determine the influence of perioperative prednisolone on clinical and laboratory inflammatory markers.

Main Methods:

  • Prospective study involving 50 infants undergoing heart surgery at two university hospitals.
  • Patients were randomized to receive either prednisolone (30 mg/kg) in the CPB priming solution or no steroids.
  • Clinical outcomes (inotropic support, oxygenation) and inflammatory markers (leukocytes, CRP, IL-8) were monitored postoperatively.

Main Results:

  • Postoperative recovery, including inotropic support and oxygenation, was similar between steroid and non-steroid groups, adjusted for surgical complexity.
  • A significant inflammatory response was observed post-CPB, particularly in patients with longer bypass times.
  • Postoperative interleukin-8 levels correlated positively with CPB duration (r = 0.62, p < 0.001).
  • Steroid administration showed no significant effect on laboratory inflammatory parameters or overall postoperative recovery.

Conclusions:

  • Perioperative prednisolone administration into the CPB priming solution did not measurably improve postoperative recovery in infants undergoing heart surgery.
  • Steroid administration did not suppress the systemic inflammatory response induced by cardiopulmonary bypass.
  • The duration of CPB time is a significant factor associated with the postoperative inflammatory response, independent of steroid use.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...